These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6928728)

  • 1. Chronic myelogenous leukemia: a 22-year survival.
    Stein RS; Flexner JM
    South Med J; 1980 Mar; 73(3):399-400. PubMed ID: 6928728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of results of treatment with myleran in 100 cases of chronic myelogenous leukemia].
    Pawelski S; Topolska P; Rechowicz K; Krzyzanowska-Woźniakows
    Pol Arch Med Wewn; 1968; 41(2):249-57. PubMed ID: 5248892
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed toxic effect of busulfan on the marrow.
    Ganda OP; Mangalik A
    J Assoc Physicians India; 1973 Jun; 21(6):511-6. PubMed ID: 4525264
    [No Abstract]   [Full Text] [Related]  

  • 4. Remission induction in chronic granulocytic leukaemia using intermittent high-dose busulphan.
    Douglas ID; Wiltshaw E
    Br J Haematol; 1978 Sep; 40(1):59-64. PubMed ID: 280361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia.
    Bolin RW; Robinson WA; Sutherland J; Hamman RF
    Cancer; 1982 Nov; 50(9):1683-6. PubMed ID: 6956430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with prolonged survival in chronic myeloid leukemia.
    Wolf DJ; Silver RT; Coleman M
    Cancer; 1978 Oct; 42(4):1957-63. PubMed ID: 280416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B.
    Silver RT; Mick R; Cooper R; Ellison RR; Levy R; Brunner K; Schwartz JM; Holland JF
    Cancer; 1987 Oct; 60(7):1442-8. PubMed ID: 3113712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of patients with chronic myeloid leukemia diagnosed and treated at the Chaim Sheba Medical Center during the years 1966-76.
    Inbal A; Modan M; Many A
    Isr J Med Sci; 1978 Dec; 14(12):1259-64. PubMed ID: 285048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic irradiation following chemotherapy in chronic myelogenous leukemia.
    Wilson JF; Johnson RE
    Radiology; 1971 Dec; 101(3):657-61. PubMed ID: 5288778
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. A peculiar pathologic aspect of busulfan lung?
    Aymard JP; Gyger M; Lavallee R; Legresley LP; Desy M
    Cancer; 1984 Feb; 53(4):954-6. PubMed ID: 6581857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic sialadenitis. A toxic effect of prolonged busulfan therapy for chronic myelogenous leukaemia (author's transl)].
    Morales Polanco MR; Butron L; Echegoyen G; Pizzuto Chavez J
    Sangre (Barc); 1977; 22(2):243-51. PubMed ID: 266289
    [No Abstract]   [Full Text] [Related]  

  • 12. Busulfan lung.
    Pearl M
    Am J Dis Child; 1977 Jun; 131(6):650-2. PubMed ID: 266839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 14. [Varying course of pancytopenia after busulfan treatment of chronic myelocytic leukemia (CML)].
    Krug K; Stenzel L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):181-7. PubMed ID: 79522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myelogenous leukemia. Prolonged survival with spontaneous decline in the frequency of Ph1-positive cells and subsequent development of mixed Ph1-positive and Ph1-negative blast crisis.
    Appelbaum FR; Najfeld V; Singer JW
    Cancer; 1983 Jan; 51(1):149-53. PubMed ID: 6571793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 13-years remission in chronic myelocytic leukemia after a single course of busulfan.
    Weinberger A; Benjamin D; Douer D; Barabash G; Djaldetti M; Pinkhas J
    Acta Haematol; 1978; 59(6):354-9. PubMed ID: 97894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.
    Hiraoka A; Masaoka T; Shibata H; Miyazaki T; Nakamura T; Yasunaga K; Kitani T; Yonezawa T; Kawagoe H; Horiuchi A
    Leuk Res; 1988; 12(6):487-90. PubMed ID: 3043111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose busulfan with subsequent bone marrow transplantation in poor-risk forms of leukemia].
    Urban C; Slavc I; Kaulfersch W; Teubl I
    Wien Klin Wochenschr; 1987 Mar; 99(5):144-9. PubMed ID: 3554777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in chronic granulocytic leukemia. Splenic irradiation vs busulfan.
    Conrad FG
    Arch Intern Med; 1973 May; 131(5):684-5. PubMed ID: 4512787
    [No Abstract]   [Full Text] [Related]  

  • 20. Splenic irradiation in chronic myeloid leukemia.
    Hukku S; Baboo HA; Venkataratnam S; Vidyasagar MS; Patel NL
    Acta Radiol Oncol; 1983; 22(1):9-12. PubMed ID: 6305140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.